A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/335 (2006.01) A61P 17/02 (2006.01)
Patent
CA 2570754
A pharmaceutical formulation and its use. The pharmaceutical formulation contains peroxidic species or reaction products resulting from oxidation of an alkene, such as geraniol, by an oxygen-containing oxidizing agent, such as ozone; a penetrating solvent, such as dimethylsulfoxide ("DMSO"); a dye containing a chelated metal, such as hematoporphyrin; and an aromatic redox compound, such as benzoquinone. The pharmaceutical formulation is used to effectively resolve scar tissue, particularly scar tissue resulting from a burn, and to treat patients with bum-related injuries.
L'invention concerne une préparation pharmaceutique et son utilisation. Cette préparation pharmaceutique contient des espèces peroxydiques ou des produits de réaction résultant de l'oxydation d'un alcène, tels que le géraniol, par un agent oxydant contenant de l'oxygène, tel que l'ozone ; un solvant pénétrant, tel que le diméthylsulfoxyde (DMSO) ; un colorant contenant un métal chélaté, tel que l'hématoporphyrine ; et un composé redox aromatique, tel qu'une benzoquinone. La préparation pharmaceutique est utilisée pour soigner efficacement des cicatrices, et plus particulièrement des cicatrices laissées par une brûlure, et pour traiter des patients souffrant de lésions dues à des brûlures.
Hofmann Robert F.
Kirby Eades Gale Baker
Torquin Llc
LandOfFree
Use of targeted oxidative therapeutic formulation in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of targeted oxidative therapeutic formulation in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of targeted oxidative therapeutic formulation in... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1994838